New patent for Alnylam Pharms drug AMVUTTRA

   September 3, 2022    Comments Off on New patent for Alnylam Pharms drug AMVUTTRA    Posted in: Patent Added

Annual Drug Patent Expirations for AMVUTTRA Amvuttra is a drug marketed by Alnylam Pharms Inc and is included in one NDA. The generic ingredient in AMVUTTRA is vutrisiran. Additional details…

The post New patent for Alnylam Pharms drug AMVUTTRA appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog